Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Polyna Khudyakov

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
British Journal of Clinical Pharmacology|March 12, 2022
A phase 1 study to evaluate the safety, tolerability and pharmacokinetics of TAK-041 in healthy participants and patients with stable schizophreniaWei Yin, David Han, Polyna Khudyakov, et al.
Clinical and Translational Science|February 26, 2022
Evaluation of the pharmacokinetics of trazpiroben (TAK-906) in the presence and absence of the proton pump inhibitor esomeprazoleJatinder Kaur Mukker, George Dukes, Lisi Wang, et al.
Journal of Attention Disorders|March 3, 2025
Exploring Risk Factors for ADHD Among Children at a Mongolian Public School: A Cross-Sectional AnalysisMallika Iyer, Adrian R Martineau, Polyna Khudyakov, et al.
Nutrients|October 16, 2025
Vitamin D Status, Fasting Blood Glucose, and Latent Tuberculosis Infection in a High-Risk Population in Ulaanbaatar, MongoliaDavaasambuu Ganmaa, Sukhbaatar Ariunbuyan, Polyna Khudyakov, et al.
British Journal of Clinical Pharmacology|July 9, 2021
Safety, pharmacokinetics and quantitative EEG modulation of TAK-071, a novel muscarinic M1 receptor positive allosteric modulator, in healthy subjectsWei Yin, Fahimeh Mamashli, Derek L Buhl, et al.
The Journal of Antimicrobial Chemotherapy|April 8, 2017
Switching to second-line ART in relation to mortality in a large Tanzanian HIV cohortClaudia Hawkins, Ellen Hertzmark, Donna Spiegelman, et al.
BMC Cardiovascular Disorders|March 2, 2019
Nepal Pioneer Worksite Intervention Study to lower cardio-metabolic risk factors: design and protocolArchana Shrestha, Dipesh Tamrakar, Biraj Man Karmacharya, et al.
British Journal of Clinical Pharmacology|May 15, 2021
Safety, pharmacokinetics and pharmacodynamics of TAK-418, a novel inhibitor of the epigenetic modulator lysine-specific demethylase 1AWei Yin, Dimitrios Arkilo, Polyna Khudyakov, et al.
BMC Infectious Diseases|June 19, 2019
Risk factors for active tuberculosis in 938 QuantiFERON-positive schoolchildren in Mongolia: a community-based cross-sectional studyDavaasambuu Ganmaa, Polyna Khudyakov, Uyanga Buyanjargal, et al.
Lancet (London, England)|December 16, 2014
Effect of neonatal vitamin A supplementation on mortality in infants in Tanzania (Neovita): a randomised, double-blind, placebo-controlled trialHonorati Masanja, Emily R Smith, Alfa Muhihi, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
British Journal of Clinical Pharmacology|March 12, 2022
A phase 1 study to evaluate the safety, tolerability and pharmacokinetics of TAK-041 in healthy participants and patients with stable schizophreniaWei Yin, David Han, Polyna Khudyakov, et al.
Clinical and Translational Science|February 26, 2022
Evaluation of the pharmacokinetics of trazpiroben (TAK-906) in the presence and absence of the proton pump inhibitor esomeprazoleJatinder Kaur Mukker, George Dukes, Lisi Wang, et al.
Journal of Attention Disorders|March 3, 2025
Exploring Risk Factors for ADHD Among Children at a Mongolian Public School: A Cross-Sectional AnalysisMallika Iyer, Adrian R Martineau, Polyna Khudyakov, et al.
Nutrients|October 16, 2025
Vitamin D Status, Fasting Blood Glucose, and Latent Tuberculosis Infection in a High-Risk Population in Ulaanbaatar, MongoliaDavaasambuu Ganmaa, Sukhbaatar Ariunbuyan, Polyna Khudyakov, et al.
British Journal of Clinical Pharmacology|July 9, 2021
Safety, pharmacokinetics and quantitative EEG modulation of TAK-071, a novel muscarinic M1 receptor positive allosteric modulator, in healthy subjectsWei Yin, Fahimeh Mamashli, Derek L Buhl, et al.
The Journal of Antimicrobial Chemotherapy|April 8, 2017
Switching to second-line ART in relation to mortality in a large Tanzanian HIV cohortClaudia Hawkins, Ellen Hertzmark, Donna Spiegelman, et al.
BMC Cardiovascular Disorders|March 2, 2019
Nepal Pioneer Worksite Intervention Study to lower cardio-metabolic risk factors: design and protocolArchana Shrestha, Dipesh Tamrakar, Biraj Man Karmacharya, et al.
British Journal of Clinical Pharmacology|May 15, 2021
Safety, pharmacokinetics and pharmacodynamics of TAK-418, a novel inhibitor of the epigenetic modulator lysine-specific demethylase 1AWei Yin, Dimitrios Arkilo, Polyna Khudyakov, et al.
BMC Infectious Diseases|June 19, 2019
Risk factors for active tuberculosis in 938 QuantiFERON-positive schoolchildren in Mongolia: a community-based cross-sectional studyDavaasambuu Ganmaa, Polyna Khudyakov, Uyanga Buyanjargal, et al.
Lancet (London, England)|December 16, 2014
Effect of neonatal vitamin A supplementation on mortality in infants in Tanzania (Neovita): a randomised, double-blind, placebo-controlled trialHonorati Masanja, Emily R Smith, Alfa Muhihi, et al.
Pageof 3